Home / Journals / CJU / Vol.17, Suppl.1, 2010
Special Issues
Table of Content
  • Open AccessOpen Access

    EDITORIAL

    A New Update: Urology Best Practices for the Primary Care Physician (PCP)

    Jack Barkin
    Canadian Journal of Urology, Vol.17, Suppl.1, pp. 1-1, 2010
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Erectile dysfunction and low testosterone: cause or an effect?

    Jack Barkin
    Canadian Journal of Urology, Vol.17, Suppl.1, pp. 2-11, 2010
    Abstract Studies have repeatedly confi rmed that about 52% of men between the ages of 40 and 70 years have some degree of erectile dysfunction (ED). Other studies have shown that as a man ages, his testosterone level will naturally decrease. Over the last number of years, we have also seen that ED may be one of the earliest signs and markers of endothelial dysfunction. There appears to be an overlap between ED, metabolic syndrome, and symptomatic late onset hypogonadism (SLOH).
    It is very important for the primary care physician to identify patients who are suffering from More >

  • Open AccessOpen Access

    ARTICLE

    Overactive bladder symptoms in women: current concepts in patient management

    William A. Easton
    Canadian Journal of Urology, Vol.17, Suppl.1, pp. 12-17, 2010
    Abstract The symptoms of overactive bladder (OAB) -- urinary urgency, frequency, and urge incontinence -- can cause signifi cant lifestyle limitations. Social isolation, depression, employment diffi culties, and relationship stress are common fi ndings in patients with this condition. This article focuses on women with OAB who are seen in primary care. Occasionally, OAB (or detrusor overactivity) may be the result of neurological disease, metabolic disease, or urinary tract abnormalities. Primary care practitioners can play a key role in identifying affected individuals by including a focused question in every annual patient physical assessment. Investigation and treatment More >

  • Open AccessOpen Access

    ARTICLE

    Prostate-specifi c antigen tests and prostate cancer screening: an update for primary care physicians

    John S. Kell
    Canadian Journal of Urology, Vol.17, Suppl.1, pp. 18-25, 2010
    Abstract Prostate cancer is a highly prevalent malignancy. Using serum prostatic-specifi c antigen (PSA) levels to screen for prostate cancer has led to a greater detection of this cancer, at earlier stages. However, screening for prostate cancer by determining PSA levels remains controversial. Concerns include the risk of overdiagnosis and conversely, the failure to detect all prostate cancers. This article, aimed at primary care practitioners, reviews the characteristics of an ideal screening test, in relation to the characteristics of the PSA test. It then discusses the implications of recent fi ndings from two large, randomized, prospective More >

  • Open AccessOpen Access

    ARTICLE

    Management of benign prostatic hyperplasia by family physicians

    Allan Toguri1, Jack Barkin2
    Canadian Journal of Urology, Vol.17, Suppl.1, pp. 26-34, 2010
    Abstract The past decade has profoundly changed how physicians manage patients with benign prostatic hyperplasia (BPH). The concepts of symptom indices, symptom complexes, fl ow rates, prostate-specifi c antigen (PSA), prostate size and new medical approaches supported by new clinical studies, have provided family practitioners as well as specialists with evidence-based management algorithms to treat BPH. Men with BPH most often visit a physician due to their partner’s urging because of the many symptoms, with the most bothersome being nocturia. Today, primary care physicians are the gatekeepers for diagnosing and managing lower urinary tract symptoms (LUTS) More >

  • Open AccessOpen Access

    ARTICLE

    Uropharmacology in primary care: 2010 update

    Leonard G. Gomella1, Costas D. Lallas1, Robert Perkel2, Christine Folia3, Irvin Hirsch1, Akhil Das1, Patrick Shenot1
    Canadian Journal of Urology, Vol.17, Suppl.1, pp. 35-51, 2010
    Abstract Many disorders such as erectile dysfunction, overactive bladder, hypogonadism and benign prostatic hypertrophy have traditionally been managed primarily by urologists. The development of newer agents to treat many of these conditions has allowed the primary care provider to manage many of these common conditions. The use of these newer medications has become commonplace in the primary care setting. This article will update some of the most commonly used urologic medications to optimize patient management strategies by the primary care provider or in coordination with the urologist. More >

Per Page:

Share Link